by admin_63069 | Apr 23, 2025 | Related Topics
Panelists discuss how prospective randomized data demonstrate that PSMA PET-CT exhibits superior diagnostic accuracy compared with conventional imaging in detecting pelvic nodal and distant metastases in patients with high-risk prostate cancer.
by admin_63069 | Apr 21, 2025 | News You Can Use
AI can help patients decide whether active surveillance is right for them.
by admin_63069 | Apr 16, 2025 | Related Topics
“Four years following radiation therapy, there is a 25% lower hazard of bowel disorders and a 46% lower hazard of related procedures [in patients who received a spacer],” says Michael R. Folkert, MD, PhD.
by admin_63069 | Apr 14, 2025 | News You Can Use
Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by conventional imaging.
by admin_63069 | Apr 9, 2025 | Related Topics
The better the systemic therapy, immunotherapy, or targeted therapy, the more important a non-invasive, local treatment will be.
